Archive for September, 2009

The new blood-thinner dabigatran is shown to protect against stroke, blood clotting and major bleeding as effectively as the currently widely used Coumadin® (warfarin), but with fewer side effects, according to an article reviewed by F1000 Medicine Faculty Members Robert Ruff, Brian Olshansky and Luis Ruilope. The original paper, Dabigatran versus warfarin in patients with […]

Rasagiline, a medication currently used to treat the symptoms of Parkinson’s disease, may also slow the rate of disease progression, according to one of the largest studies ever conducted in Parkinson’s disease (PD), which was reported in The New England Journal of Medicine. Known as ADAGIO (Attenuation of Disease Progression with Azilect Given Once Daily), […]

Monell.org – Oleocanthal, a natural phytochemical found in extra-virgin olive oil (EVOO), alters the structure of neurotoxic proteins called ADDLs believed to contribute to the debilitating effects of Alzheimer’s disease. This structural change impedes the proteins’ ability to damage brain nerve cells. “The findings may help identify effective preventative measures and lead to improved therapeutics […]

While the occasional all-nighter to cram for exams or finish a grant proposal may seem like no big deal, chronic or frequent sleep deprivation could take its toll on brain health in later life, two new studies suggest. Based on microdialysis experiments in live mice, Dave Holtzman, Washington University, St. Louis, Missouri, and colleagues report […]

The first – and only – national clinical practice guideline to help healthcare practitioners identify and manage patients with hoarseness, also known as dysphonia, is being issued by The American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF). The hoarseness guideline emphasizes evidence-based management of hoarseness by clinicians, and educates patients on the […]

Jefferson.edu – The FDA-cleared Neuromonics Tinnitus Treatment is now offered by The Jefferson Balance and Hearing Center of the Department of Otolaryngology – Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia. This therapy is proven to interact, interrupt and desensitize tinnitus by delivering a customized neural stimulus, embedded in clinically modified music. […]